RBC Capital lowered the firm’s price target on Acadia Healthcare (ACHC) to $22 from $28 and keeps an Outperform rating on the shares, updating the firm’s model after the company’s Q3 results last week. Weaker Medicaid volume and increased bad debt expense was the primary driver of the company’s weaker performance and revised 2025 outlook, the analyst tells investors in a research note.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare Settles $179M Securities Litigation
- Acadia Healthcare price target lowered to $27 from $29 at Guggenheim
- Acadia Healthcare’s Earnings Call: Mixed Sentiments and Strategic Moves
- Optimistic Buy Rating for Acadia Healthcare Amid Strategic Growth Initiatives
- Acadia Healthcare price target lowered to $22 from $25 at Cantor Fitzgerald